Neuropathic Pain, Depressive Symptoms, and C-Reactive Protein in Sciatica Patients

REFERENCES

• Strigo IA, Simmons AN, Matthews SC, Craig AD, Paulus MP. Major depressive disorder is associated with altered functional brain response during anticipation and processing of heat pain. Arch Gen Psychiatry. 2008;65:1275–84.
   PubMed Web of Science ®Google Scholar
• Linton SJ. A review of psychological risk factors in back and neck pain. Spine (Phila Pa 1976). 2000;25:1148–56.
   PubMed Web of Science ®Google Scholar
• Shaw WS, Means-Christensen AJ, Slater MA, Webster JS, Patterson TL, Grant I, Garfin SR, Wahlgren DR, Patel S, Atkinson JH. Psychiatric disorders and risk of transition to chronicity in men with first onset low back pain. Pain Med. 2010;11(9):1391–400.
   PubMed Web of Science ®Google Scholar
• Fishbain DA, Cutler R, Rosomoff HL. Chronic pain-associated depression: antecedent or consequence of chronic pain? Clin J Pain. 1997;13:116–37.
   PubMed Web of Science ®Google Scholar
• Freynhagen R, Baron R, Gockel U, Tölle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22:1911–20.
   PubMed Web of Science ®Google Scholar
• Hill JC, Konstantinou K, Egbewale BE, Dunn KM, Lewis M, van der Windt D. Clinical outcome among low back pain consulters with referred leg pain in primary care. Spine (Phila Pa 1976). 2011;36(25):2168–75.
   PubMed Web of Science ®Google Scholar
• LaCaille RA, DeBerard MS, Masters KS, Colledge AL, Bacon W. Presurgical biopsychosocial factors predict multidimensional patient: outcomes of interbody cage lumbar fusion. Spine J. 2005;5:71–8.
   PubMedGoogle Scholar
• Edwards RR, Klick B, Buenaver L, Max MB, Haythornthwaite JA, Keller RB, Atlas SJ. Symptoms of distress as prospective predictors of pain-related sciatica treatment outcomes. Pain. 2007;130(1-2):47–55.
   PubMed Web of Science ®Google Scholar
• Carragee EJ. Psychological screening in the surgical treatment of lumbar disc herniation. Clin J Pain. 2001;17: 215–9.
   PubMed Web of Science ®Google Scholar
• Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9), 32–41.
   Web of Science ®Google Scholar
• Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–57.
   PubMed Web of Science ®Google Scholar
• Pabreja K, Dua K, Sharma S, Padi SS, Kulkarni SK. Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms. Eur J Pharmacol. 2011;661:15–21.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Hasegawa-Moriyama M, Sakurai T, Inada E. The macrophage-mediated effects of the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuate tactile allodynia in the early phase of neuropathic pain development. Anesth Analg. 2011;113:398–404.
   PubMed Web of Science ®Google Scholar
• Surtees PG, Wainwright NW, Boekholdt SM, Luben RN, Wareham NJ, Khaw KT. Major depression, C-reactive protein, and incident ischemic heart disease in healthy men and women. Psychosom Med. 2008;70(8):850–5.
   PubMed Web of Science ®Google Scholar
• DeLeo JA, Colburn RW, Nichols M, Malhotra A. Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J Interferon Cytokine Res. 1996;16:695–700.
   PubMed Web of Science ®Google Scholar
• Arruda JL, Colburn RW, Rickman AJ, Rutkowski MD, DeLeo JA. Increase of interleukin-6 mRNA in the spinal cord following peripheral nerve injury in the rat: potential role of IL-6 in neuropathic pain. Brain Res Mol Brain Res. 1998;62: 228–35.
   PubMedGoogle Scholar
• Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett. 2004;361:184–7.
   PubMed Web of Science ®Google Scholar
• Zelenka M, Schafers M, Sommer C. Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain. 2005;116:257–63.
   Web of Science ®Google Scholar
• Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;34:448–54.
   Google Scholar
• Stürmer T, Raum E, Buchner M, Gebhardt K, Schiltenwolf M, Richter W, Brenner H. Pain and high sensitivity C reactive protein in patients with chronic low back pain and acute sciatic pain. Ann Rheum Dis. 2005;64:921–5.
   PubMed Web of Science ®Google Scholar
• Cruccu G, Sommer C, Anand P, Attal N, Baron R, Garcia-Larrea L, Haanpaa M, Jensen TS, Serra J, Treede RD. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol. 2010;17:1010–8.
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA, Brown GK. Manual for beck depression inventory-II. San Antonio (TX): Psychological Corporation; 1996.
   Google Scholar
• Zung WWK. A rating instrument for anxiety disorders. Psychosomatics. 1971;12:371–9.
   PubMed Web of Science ®Google Scholar
• Bagby RM, Taylor GJ, Parker JD. The twenty-item Toronto Alexithymia Scale–II. Convergent, discriminant, and concurrent validity. J Psychosom Res. 1994;38(1):33–40.
   PubMed Web of Science ®Google Scholar
• Gebhardt K, Brenner H, Stürmer T, Raum E, Richter W, Schiltenwolf M, Buchner M. The course of high-sensitive C-reactive protein in correlation with pain and clinical function in patients with acute lumbosciatic pain and chronic low back pain—A 6 months prospective longitudinal study. Eur J Pain. 2006;10:711–9.
   PubMed Web of Science ®Google Scholar